Clinical Trial Update: Pilot Study of 99mTc-MIP-1404 SPECT/CT Imaging in Men With Prostate Cancer Undergoing Prostatectomy and/or Pelvic Lymph Node Dissection [Phase 1]

View source ↗

Summary

A pilot Phase 1 study assessing 99mTc-MIP-1404 SPECT/CT imaging in men with prostate cancer undergoing prostatectomy and/or pelvic lymph node dissection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 99mTc-MIP-1404 (Technetium-99m MIP-1404)

Snippet

Sponsor: Molecular Insight Pharmaceuticals, Inc. | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED